Pancreatic cancer is difficult to detect early because the pancreas is located deep in the abdomen, preventing small, early-stage tumours from being felt during exams or easily seen on imaging. Additionally, symptoms are vague, such as indigestion or mild back pain, mimicking other conditions, and often do not appear until the tumour has grown or spread. By the time most patients receive a diagnosis, the cancer has already moved past the stage where surgical cure was still a realistic option.
According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Pancreatic cancer hides because of its anatomy and because its early signals are exactly the kind nobody investigates aggressively until something dramatic forces the issue, which is usually too late to change the outcome.”
Why Does This Cancer Stay Hidden So Long?
Not one reason. Several, all working together, and the combination is what makes pancreatic cancer different from most other GI cancers.
- Anatomy: Pancreas tucked behind the stomach, surrounded by bowel loops and fat, ultrasound barely reaches it properly and CT misses tumours under 2 cm more often than most patients or their doctors realise.
- Symptoms: Upper abdominal discomfort, mild back pain, appetite dropping off, slow weight loss. Every single one of these gets blamed on something else, acidity, gastritis, work stress, ageing, for months before anyone even considers the pancreas.
- Diabetes: New diabetes after 50 in someone who isn’t overweight and has no metabolic history. That’s a red flag. But most doctors start metformin and move on without ever ordering a pancreatic scan, and the tumour keeps growing while the blood sugar gets managed as a standalone problem.
- No Screening: Colonoscopy catches colorectal cancer early. Mammography catches breast cancer early. Pancreatic cancer has nothing equivalent, so unless a patient is already in a high-risk surveillance programme, nobody is looking until symptoms force the conversation.
These factors reinforce each other in ways that keep pushing diagnosis later, and specialist in pancreatic cancer treatment uses EUS whenever clinical suspicion exists rather than waiting for CT to eventually declare something that should have been found months earlier.
How Do You Actually Catch It Early?
Right investigation. Right patient. Right timing. Not hoping the next scan shows what the last one missed.
- EUS: Imaging probe positioned millimetres from the pancreas through the stomach wall. Picks up sub-2 cm tumours CT misses. Biopsy in the same session. This is the most effective early detection tool available and the reason patients with inconclusive CT findings should be moving toward EUS, not repeating the same scan again.
- Surveillance: BRCA2 carriers, first-degree relatives of pancreatic cancer patients, hereditary pancreatitis. All need annual EUS. Finding a small lesion before symptoms develop is the only proven way to catch this cancer at genuinely curable stage in people with genetic predisposition.
- Symptom Clusters: Persistent upper abdominal pain plus unexplained weight loss. New diabetes after 50 plus painless jaundice. Any combination of these in the same patient over a short period warrants EUS, not another round of acid suppression and a follow-up appointment in six weeks.
- Next Step: CT inconclusive or symptoms persisting despite normal scans. EUS should be the immediate next investigation. Not a repeat CT in three months. Three months of pancreatic cancer growth is exactly the kind of delay that changes a resectable tumour into an unresectable one.
Catching pancreatic cancer early requires the right tool at the right decision point, not luck. Read more on warning signs to understand which specific signals deserve aggressive investigation and which patient profiles need a much lower threshold for imaging than the general population.
Why choose Dr. Vipulroy Rathod to detect pancreatic cancer ?
Dr. Vipulroy Rathod has spent over 30 years catching pancreatic cancer through EUS, fine needle aspiration, and structured high-risk surveillance at Fortis Hospital Mulund. Small resectable tumours in patients whose CT scans had been called normal. Diagnoses made where other pathways had stopped looking. Physicians from 35 countries trained in this specific approach.
Most patients arrive after months of reassurance that nothing was wrong, and many leave with a real diagnosis caught early enough to actually treat. That gap between reassurance and reality is exactly what proper investigation closes.
📞 Call Now: +91 9820091763
Book your consultation today with one of India’s most experienced specialists for detecting pancreatic cancer.
Frequently Asked Questions
The pancreas sits deep in the abdomen, early symptoms are vague, and no routine screening exists outside high-risk patient groups.
Yes, EUS surveillance can find small pancreatic lesions in high-risk patients before any symptoms appear.
No, CT often misses pancreatic tumours under 2 cm and EUS is required for accurate early detection in most cases.
BRCA2 carriers, patients with familial pancreatic cancer, and those with hereditary pancreatitis benefit most from annual EUS surveillance.
Reference links-
- Pancreatic Cancer Early Detection Challenges — American Society for Gastrointestinal Endoscopy
- Pancreatic Cancer Surveillance Guidelines — World Gastroenterology Organisation